Tablets & Capsules

TC0419

Issue link: https://www.e-digitaleditions.com/i/1101841

Contents of this Issue

Navigation

Page 22 of 55

Tablets & Capsules April 2019 21 As previously stated, it's important to achieve effec- tive taste masking without compromising drug release (unless a modified release characteristic is desirable). As shown in Figure 9, mini-tablets coated with a stan- dard HPMC-based film coating (Aquarius Prime) and a special taste-masking film coating (Aquarius Protect) show similar dissolution behavior, and the dissolution profiles compare favorably to that of the uncoated mini-tablets, easily meeting the required Q value for the tested API. As Figures 6 and 7 show, the coated API-containing mini-tablets produced the most effective taste-masking qualities at 15 and 20 percent when compared to the API comparator and at 20 percent when compared to the placebo comparator. An example of a principal compo- nent map is shown in Figure 8. In this case, testing was performed after 10 minutes mixing in the test fluid, where taste-masking effectiveness (compared to the API comparator) was greatest for mini-tablets coated with the Aquarius Protect film coating at 30 percent. Figure 8 Principal component map (Testing performed after 10 minutes stirring in test fluid) Figure 9 Dissolution profiles for uncoated and coated mini-tablets (20 percent weight gain) Drug release (percent) DI water 100 80 60 40 20 0 0 5 10 15 20 25 30 35 40 45 50 55 60 65 Uncoated Aquarius Prime Aquarius Protect BWT Time (minutes) Figure 7 Taste-masking effectiveness versus coated placebo comparator Distance to reference 600 500 400 300 200 100 0 Uncoated (10%) (15%) (20%) (10%) (15%) (20%) Aquarius Protect Aquarius Prime Figure 6 Taste-masking effectiveness versus API comparator (10%) (15%) (20%) (10%) (15%) (20%) Aquarius Protect Aquarius Prime Distance to reference 600 500 400 300 200 100 0

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0419